A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre
Cheema, Parneet K, Iafolla, Marco A J, Nematollahi, Massey, Berco, FeRevelyn, Kaushik, Deepanjali, Matthews, Priscilla, Raskin, William R, Perdrizet, Kirstin A, Dudani, Shaan, Husain, Juhi, Balcewicz, Margaret, Kuruvilla, Philip G, Reingold, Stephen M, Conter, Henry J
Published in Current oncology (Toronto) (04.02.2022)
Published in Current oncology (Toronto) (04.02.2022)
Get full text
Journal Article
Impact of an immuno-oncology (IO) education/monitoring program on patient’s self-efficacy and adverse event reporting from immune checkpoint inhibitors (ICIs)
Cheema, Parneet Kaur, Nematollahi, Massey, Berco, FeRevelyn, Papadakos, Janet, Kaushik, Deepanjali, Matthews, Priscilla, Iafolla, Marco, Perdrizet, Kirstin, Balcewicz, Margaret, Raskin, William, Reingold, Stephen, Husain, Juhi, Kuruvilla, Philip, Conter, Henry Jacob
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article